Epitomee Medical announced the completion of $51 million IPO on the Tel Aviv Stock Exchange; The offering was made at a pre-money valuation of $200 million
/PRNewswire/ -- Epitomee Medical (TASE: EPIT), the Israel-based bio-medical company, announced this morning the completion of its Initial Public Offering on...
Source: prnewswire.com